Physician profile
Patrick G Mccallion
NPI 1134144454
$6,445.91
in general payments reported to CMS, 2019-2025
26 companies · $1,107 in 2025
The $1,107 reported for 2025 was more than what 81% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,375 · 2020: $430 · 2021: $1,024 · 2022: $750 · 2023: $730 · 2024: $1,031 · 2025: $1,107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,799 · Education: $67.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,799.32 |
| Education | $67.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,164.17 | 2019-2025 | Scopis Ent, Latera, Clarifix Cryotherapy Device |
| Optinose US, INC. | $1,067.56 | 2019-2025 | |
| Genzyme Corporation | $897.59 | 2022-2025 | |
| Glaxosmithkline, LLC. | $743.16 | 2021-2025 | Nucala |
| Aerin Medical INC. | $309.87 | 2019-2025 | |
| Medtronic, INC. | $214.75 | 2023-2024 | Propel, Sonicision, Nuvent |
| Haag-Streit USA, INC. | $150.45 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $135.39 | 2025 | Tezspire |
| Neurent Medical Limited | $113.53 | 2022-2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Regeneron Healthcare Solutions, INC. | $78.78 | 2023-2025 | Dupixent |
| Smith+Nephew, INC. | $69.29 | 2019-2025 | Tula, Coblation, Rf20000 |
| Resmed Corp | $67.47 | 2025 | |
| Intersect Ent, INC. | $61.17 | 2019-2022 | |
| Hologic Sales and Service, LLC | $52.93 | 2023 | Coolseal Generator |
| Pfizer INC. | $40.92 | 2024-2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $34.07 | 2022 | |
| Arrinex, INC. | $33.27 | 2019 | |
| Acera Surgical, INC. | $30.96 | 2023-2024 | Restrata Wound Matrix |
| Aroa Biosurgery Incorporated | $30.66 | 2022 | |
| Inspire Medical Systems, INC. | $29.78 | 2023 | Inspire |
| Hospira, INC. | $27.89 | 2022 | |
| Merck Sharp & Dohme LLC | $24.77 | 2023 | |
| Amgen INC. | $24.51 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $16.64 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Hikma Pharmaceuticals USA | $13.60 | 2025 | Ryaltris |
| Ethicon US, LLC | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mccallion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.